FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

TGA Seeks Broader Authority to Penalize False Drug Advertising

May 17, 2017

Australia’s Therapeutic Goods Administration is proposing to expand its authority to impose sanctions and penalties for non-compliant ads.

Among other proposed changes, TGA could require companies to provide documentation or evidence for a claim they made in advertising material. The information would allow the agency to determine whether more comprehensive investigations are necessary. Failure to respond within 21 days would result in a fine of up to AUS $5,400 ($3,978), with proposed penalties of up to twice that for providing false information.

The agency also proposes to seek authority to issue public notices for suspected non-compliant advertising in cases where it could potentially lead to human harm.

TGA said it would use the new powers, in part, to target fraudulent cancer treatments.

View today's stories